Panel Discussion: Developing Effective Precision Medicine Strategies for ADCs to Improve Patient Stratification & Enhance Treatment Efficacy

• What are the most critical biomarkers for ADC target selection and patient stratification today?
• How can digital pathology, IHC, and genomics platforms elevate ADC trials?
• What are the best practices for navigating diagnostic regulatory pathways?
• How to design testing networks to ensure equitable diagnostic access

Speakers:

Devrim Emel Alici

Medical Director, Singapore

AstraZeneca

Crystal Wang

Oncology Therapeutic Area Medical Lead, Singapore, Malaysia & Brunei

Astellas Pharma